1,580
Views
2
CrossRef citations to date
0
Altmetric
Commentary and Views

The importance of the gut microbiome in the pathogenesis and transmission of SARS-CoV-2

Someone on Earth: “..we moved at the speed of Science!” - Science from the center of the Universe: “Hey man, I’m still waiting for you in the 50s!

ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Article: 2244718 | Received 30 Apr 2023, Accepted 01 Aug 2023, Published online: 09 Aug 2023

References

  • Zhou B, Pang X, Wu J, Liu T, Wang B, Cao H. Gut microbiota in COVID-19: new insights from inside. Gut Microbes. 2023;15(1):2201157. doi:10.1080/19490976.2023.2201157. PMID: 37078497; PMCID: PMC10120564
  • Ng SC, Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye. Gut. 2020 Jun;69(6):973–4. doi:10.1136/gutjnl-2020-321195. Epub 2020. PMID: 32273292
  • Davis HE, McCorkell L, Vogel JM, Topol EJ. Author Correction: Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(6):408. doi:10.1038/s41579-023-00896-0. Erratum for: Nat Rev Microbiol. 2023 Mar;21(3):133-146. PMID: 37069455
  • Petrillo M, Brogna C, Cristoni S, Querci M, Piazza O, Van den Eede G. Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology. F1000Res. 2021;10:370. doi:10.12688/f1000research.52540.1. PMID: 34336189.
  • Brogna C, Brogna B, Bisaccia DR, Lauritano F, Marino G, Montano L, Cristoni S, Prisco M, Piscopo M. Could SARS-CoV-2 have bacteriophage behavior or induce the activity of other bacteriophages? Vaccines (Basel). 2022 29;10(5):708. doi: 10.3390/vaccines10050708. PMID: 35632464.
  • Brogna C, Cristoni S, Petrillo M, Querci M, Piazza O, Van den Eede G. Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients. F1000Res. 2021;10:550. doi:10.12688/f1000research.54306.1. PMID: 35106136.
  • Brogna C, Cristoni S, Brogna B, Bisaccia DR, Marino G, Viduto V, Montano L, Piscopo M. Toxin-like peptides from the bacterial cultures derived from gut microbiome infected by SARS-CoV-2-new data for a possible role in the long COVID pattern. Biomedicines. 2022;11(1):87. doi:10.3390/biomedicines11010087. PMID: 36672595
  • Pistollato F, Petrillo M, Clerbaux LA, Leoni G, Ponti J, Bogni A, Brogna C, Cristoni S, Sanges R, Mendoza-de Gyves E, et al. Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: Possible implications for SARS-CoV-2 impact on brain development. Reprod Toxicol. 2022;111:34–48. doi:10.1016/j.reprotox.2022.04.011. Epub 2022 May 5. PMID: 35525527.
  • Brogna C, Costanzo V, Brogna B, Bisaccia DR, Brogna G, Giuliano M, Montano L, Viduto V, Cristoni S, Fabrowski M, et al. Analysis of bacteriophage behavior of a human RNA Virus, SARS-CoV-2, through the integrated approach of immunofluorescence microscopy, proteomics and D-Amino acid quantification. Int J Mol Sci. 2023;24(4):3929. doi:10.3390/ijms24043929. PMID: 36835341.
  • Madama S, Falletta E, Malvandi AM, Arzoni K, Brogna C, Varelli M, Bertelli M, Conti M, Larini M, Guidugli F, et al. Q value and parent energy optimization using a low-voltage ionization approach increases resolution in linear ion trap mass spectrometry. J Mass Spectrom. 2022;57(8):e4876. doi:10.1002/jms.4876. PMID: 35941810
  • Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698–706. doi:10.1136/gutjnl-2020-323020. Epub 2021 Jan 11. PMID: 33431578
  • Zhang F, Lau RI, Liu Q, Su Q, Chan FKL, Ng SC. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat Rev Gastroenterol Hepatol. 2023;20(5):323–337. [Epub 2022 Oct 21]. doi:10.1038/s41575-022-00698-4. Erratum in: Nat Rev Gastroenterol Hepatol. 2023 Mar;20(3):195. PMID: 36271144
  • Nagata N, Takeuchi T, Masuoka H, Aoki R, Ishikane M, Iwamoto N, Sugiyama M, Suda W, Nakanishi Y, Terada-Hirashima J. Terada-Hirashima et al.human gut microbiota and its metabolites impact immune responses in COVID-19 and its complications. Gastroenterology. 2023;164(2):272–288. doi:10.1053/j.gastro.2022.09.024. Epub 2022 Sep 23. PMID: 36155191
  • Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol. 2021;27(46):7925–7942. doi:10.3748/wjg.v27.i46.7925. PMID: 35046621
  • de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CRB. Microbiota modulation of the gut-lung axis in COVID-19. Front Immunol. 2021;12:635471. doi:10.3389/fimmu.2021.635471. PMID: 33717181.
  • Hughes DT, Sperandio V. Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol. 2008;6(2):111–120. doi:10.1038/nrmicro1836. PMID: 18197168
  • Morens DM, Taubenberger JK, Fauci AS. Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host & Microbe. 2023;31(1):146–157. doi:10.1016/j.chom.2022.11.016. PMID: 36634620